People taking GLP-1 medications may experience a range of positive effects: Lower blood sugar levels, leading to improved diabetes control Promote weight loss, which can improve overall health and lower the risk of related medical problems Lower the risk of heart attacks, strokes, and kidney disease in people with diabetes or those at high cardiovascular risk Improve liver health in people with metabolic dysfunction-associated steatotic liver disease (MASLD) Help lower blood pressure and cholesterol, supporting overall heart health Reduce appetite and food cravings, making healthy eating patterns easier to maintain Less likely than some other diabetes medicines to cause low blood sugar or unwanted weight gain Can provide meaningful and lasting results for people who have struggled to lose weight with lifestyle changes alone Are there specific lifestyle changes that work best with these medications
Eligibility typically depends on income and insurance status
Adrenalectomy study A combination anesthetic was prepared with medetomidine (0.3 mg/kg body weight
The MHRA has launched a genetic study in partnership with Genomics England to examine whether certain individuals may be genetically predisposed to developing pancreatitis after taking GLP-1 medications
Key Ozempic lawsuit takeaways Ozempic is a once-weekly injectable medication approved to treat type 2 diabetes
AstraZeneca emphasizes cardiovascular and metabolic disease expertise with a focus on comprehensive therapeutic solutions and clinical excellence